Membrane association and selectivity of the antimicrobial peptide NK-2: A molecular dynamics simulation study

Journal of Peptide Science

Volumn 15, Issue 10, 2009, Pages 654-667

  Pimthon, Jutarat ^a,b   Willumeit, Regine ^a   Lendleina, Andreas ^a   Hofmann, Dieter ^a  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anionic; Electrostatic; Lipid bilayers; Md simulations; Peptide lipid interaction; Surface binding; Zwitterionic

Indexed keywords

ANTIMICROBIAL PEPTIDE NK 2; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; WATER;

ALPHA HELIX; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; ELECTRIC POTENTIAL; HYDROPHOBICITY; LIPID BILAYER; LIPID MEMBRANE; MEMBRANE BINDING; MEMBRANE MODEL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; SURFACE CHARGE;

AMINO ACID SEQUENCE; COMPUTER SIMULATION; LIPID BILAYERS; MEMBRANES; MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

BACTERIA (MICROORGANISMS);

EID: 70449647113     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1165     Document Type: Article

References (65)

1. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55. (Pubitemid 36268398)
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
3. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life. Sci. 2007; 64: 922-933. (Pubitemid 46597762)
4. Taheri-Araghi S, Ha B-Y. Physical basis for membrane-charge selectivity of cationic antimicrobial peptides. Phys. Rev. Lett. 2007; 98: 168101-168104. (Pubitemid 46600630)
5. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005; 3: 238-250.
6. Palffy R, Gardlik R, Behuliak M, Kadasi L, Turna J, Celec P. On the physiology and pathophysiology of antimicrobial peptides. Mol. Med. 2009; 15: 51-59.
7. Oren Z, Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 1998; 47: 451-463. (Pubitemid 128637353)
8. Andra J, Leippe M. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med. Microbiol. Immunol. 1999; 188: 117-124. (Pubitemid 30085357)
9. Liepinsh E, Andersson M, Ruysschaert JM, Otting G. Saposin fold revealed by the NMR structure of NK-lysin. Nat. Struct. Biol. 1997; 4: 793-795. (Pubitemid 127742486)
10. Schroder-Borm H, Willumeit R, Brandenburg K, Andra J. Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin. Biochim. Biophys. Acta 2003; 1612: 164-171. (Pubitemid 36629570)
11. Andra J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, et al. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J. Biol. Chem. 2007; 282: 14719-14728. (Pubitemid 47093359)
12. Schroder-Borm H, Bakalova R, Andra J. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett. 2005; 579: 6128-6134. (Pubitemid 41546259)
13. Willumeit R, Kumpugdee M, Funari SS, Lohner K, Navas BP, Brandenburg K, et al. Structural rearrangement of model membranes by the peptide antibiotic NK-2. Biochim. Biophys. Acta 2005; 1669: 125-134. (Pubitemid 40704730)
14. Olak C, Muenter A, Andra J, Brezesinski G. Interfacial properties and structural analysis of the antimicrobial peptide NK-2. J. Pept. Sci. 2008; 14: 510-517. (Pubitemid 351540914)
15. Olak C. Biophysikalische Studien zur Wechselwirkung des antimikrobiellen Peptides NK-2 mit membran-mimetischen Systemen. Doctoral Dissertation, Potsdam University, Potsdam, 2008.
16. Leontiadou H, Mark AE, Marrink SJ. Antimicrobial peptides in action. J. Am. Chem. Soc. 2006; 128: 12156-12161.
17. Sengupta D, Leontiadou H, Mark A, Marrink S-J. Toroidal pores formed by antimicrobial peptides showsignificant disorder. Biochim. Biophys. Acta 2008; 1778: 2308-2317.
18. Jang H, Ma B, Woolf TB, Nussinov R. Interaction of protegrin-1 with lipid lilayers: membrane thinning effect. Biophys. J. 2006; 91: 2848-2859. (Pubitemid 44526475)
19. Fleming E, Maharaj NP, Chen JL, Nelson RB, Elmore DE. Effect of lipid composition on buforin II structure and membrane entry. Proteins 2008; 73: 480-491.
20. Hsu JCY, Yip CM. Molecular dynamics simulations of indolicidin association with model lipid bilayers. Biophys. J. 2007;92: L100-L102. (Pubitemid 46910525)
21. Lensink MF, Christiaens B, Vandekerckhove J, Prochiantz A, Rosseneu M. Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. Biophys. J. 2005; 88: 939-952. (Pubitemid 40975929)
22. Khandelia H, Kaznessis YN. Cation-π interactions stabilize the structure of the antimicrobial peptide indolicidin near membranes; moleculardynamics simulations. J. Phys. Chem. B 2007;111:242-250. (Pubitemid 46277988)
23. Appelt C, Eisenmenger F, Kuhne R, Schmieder P, Söderhäll JA. Interaction of the antimicrobial peptide Cyclo(RRWWRF) with membranes by molecular dynamics simulations. Biophys. J. 2005; 89: 2296-2306. (Pubitemid 41401021)
24. Polyansky AA, Volynsky PE, Arseniev AS, Efremov RG. Adaptation of a membrane-active peptide to heterogeneous environment. I. Structural plasticity of the peptide. J. Phys. Chem. B 2009; 113: 1107-1119.
25. Lewis RN, Zweytick D, Pabst G, Lohner K, McElhaney RN. Calorimetric, x-ray diffraction, and spectroscopic studies of the thermotropic phase behavior and organization of tetramyristoyl cardiolipin membranes. Biophys. J. 2007; 92: 3166-3177. (Pubitemid 46684577)
26. Latal A, Degovics G, Epand RF, Epand RM, Lohner K. Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. Eur. J. Biochem. 1997; 248: 938-946. (Pubitemid 27400053)
27. Seto GW, Marwaha S, Kobewka DM, Lewis RN, Separovic F, McElhaney RN. Interactions of the Australian tree frog antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1 with lipid model membranes: differential scanning calorimetric and Fourier transform infrared spectroscopic studies. Biochim. Biophys. Acta 2007; 1768: 2787-2800. (Pubitemid 350060869)
28. Abrunhosa F, Faria S, Gomes P, Tomaz I, Pessoa JC, Andreu D, et al. Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition. J. Phys. Chem. B 2005; 109: 17311-17319. (Pubitemid 41361410)
29. Shaw JE, Alattia JR, Verity JE, Prive GG, Yip CM. Mechanisms of antimicrobial peptide action: studies of indolicidin assembly at model membrane interfaces by in situ atomic force microscopy. J. Struct. Biol. 2006; 154: 42-58.
30. van Kan EJM, Ganchev DN, Snel MME, Chupin V, van der Bent A, de Kruijff B. The peptide antibiotic clavanin A interacts strongly and specifically with lipid bilayers. Biochemistry 2003; 42: 11366-11372. (Pubitemid 37158904)
31. Pott T, Dufourcq J, Dufourc EJ. Fluid or gel phase lipid bilayers to study peptide-membrane interactions? Eur. Biophys. J. 1996; 25: 55-59. (Pubitemid 26345003)
32. Pabst G, Danner S, Karmakar S, Deutsch G, Raghunathan VA. On the propensity of phosphatidylglycerols to form interdigitated phases. Biophys. J. 2007; 93: 513-525. (Pubitemid 47057817)
33. Sevcsik E, Pabst G, Jilek A, Lohner K. How lipids influence the mode of action of membrane-active peptides. Biochim. Biophys. Acta 2007; 1768: 2586-2595. (Pubitemid 47532036)
34. Sevcsik E, Pabst G, Richter W, Danner S, Amenitsch H, Lohner K. Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix. Biophys. J. 2008; 94: 4688-4699.
35. Pimthon J, Willumeit R, Lendlein A, Hofmann D. Computational modeling of anionic and zwitterionic lipid bilayers for investigating surface activities of bioactive molecules. Mater. Res. Soc. Symp. Proc. 2009; 1140: 1140-HH09-07.
36. Neville F, Cahuzac M, Konovalov O, Ishitsuka Y, Lee KY, Kuzmenko I, et al. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys. J. 2006; 90: 1275-1287.
37. Gidalevitz D, Ishitsuka Y, Muresan AS, Konovalov O, Waring AJ, Lehrer RI, et al. Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 6302-6307. (Pubitemid 36666576)
38. Brooks B, Bruccoleri R, Olafson B, States D, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 1983; 4: 187-217.
39. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 1998; 102: 3586-3616. (Pubitemid 128576688)
40. Feig M, MacKerell AD Jr, Brooks CL III. Force field influence on the observation of π-helical protein structures in molecular dynamics simulations. J. Phys. Chem. B 2003; 107: 2831-2836.
41. Feller SE, MacKerell AD. An improved empirical potential energy function formolecular simulations of phospholipids. J. Phys. Chem. B 2000; 104: 7510-7515.
42. Durell SR, Brooks BR, Ben-Naim A. Solvent-induced forces between 2 hydrophillic groups. J. Phys. Chem. B 1994; 98: 2198-2202.
43. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983; 79: 926-935.
44. Ryckaert J-P, Ciccotti G, Berendsen H. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 1977; 23: 327-341.
45. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J. Chem. Phys. 1995; 103: 8577-8593.
46. Zhang Y, Feller SE, Brooks BR, Pastor RW. Computer simulation of liquid/liquid interfaces. I. Theory and application to octane/water. J. Chem. Phys. 1995; 103: 10252-10266.
47. Feller SE, Pastor RW. On simulating lipid bilayers with an applied surface tension: periodic boundary conditions and undulations. Biophys. J. 1996; 71: 1350-1355.
48. Jensen MØ, Mouritsen OG, Peters GH. Simulations of a membraneanchored peptide: structure, dynamics, and influence on bilayer properties. Biophys. J. 2004; 86: 3556-3575. (Pubitemid 38786433)
49. Benz RW, Castro-Román F, Tobias DJ, White SH. Experimental validation of molecular dynamics simulations of lipid bilayers: a new approach. Biophys. J. 2005; 88: 805-817. (Pubitemid 40975920)
50. Pimthon J, Willumeit R, Lendlein A, Hofmann D. All atom molecular dynamics simulation studies of fully hydrated gel phase DPPG and DPPE bilayers. J. Mol. Struct. 2009; 921: 38-50.
51. Feller SE, Pastor RW. Constant surface tension simulations of lipid bilayers: the sensitivity of surface areas and compressibilities. J. Chem. Phys. 1999; 111: 1281-1287.
52. Skibinsky A, Venable RM, Pastor RW. A molecular dynamics study of the response of lipid bilayers and monolayers to trehalose. Biophys. J. 2005; 89: 4111-4121. (Pubitemid 41725631)
53. Jang H, Zheng J, Nussinov R. Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys. J. 2007; 93: 1938-1949. (Pubitemid 47437578)
54. Feller SE, Zhang Y, Pastor RW, Brooks BR. Constant pressure molecular dynamics simulation: the Langevin piston method. J. Chem. Phys. 1995; 103: 4613-4621.
55. Nose S, Klein ML. A study of solid and liquid carbon tetrafluoride using the constant pressuremolecular-dynamics technique. J. Chem. Phys. 1983; 78: 6928-6939.
56. Hoover WG. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. A 1985; 31: 1695-1697.
57. Mezei M. Simulaid: a collection of utilities designed to help setting up molecular dynamics simulations. J. Comput. Chem. 1997; 18: 812-815.
58. DeLano WL. The PyMOL Molecular Graphics System. Palo Alto, CA: DeLano Scientific; 2002.
59. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996; 14: 33-38, 27-28.
60. Kandasamy SK, Larson RG. Binding and insertion of alpha-helical anti-microbial peptides in POPC bilayers studied by molecular dynamics simulations. Chem. Phys. Lipids 2004; 132: 113-132.
61. Lohner K, Sevsik E, Pabst G. Liposome-based biomembrane mimetix systems: implications for lipid-peptide interactions. In Advances in Planar Lipid Bilayers and Liposomes, Leitmanova L (ed.). Elsevier: Amsterdam, 2008; 103-137. (Pubitemid 351970329)
62. De Loof H, Nilsson L, Rigler R. Molecular dynamics simulation of galanin in aqueous and nonaqueous solution. J. Am. Chem. Soc. 1992; 114: 4028-4035.
63. Shin SY, Kang JH, Jang SY, Kim Y, Kim KL, Hahm KS. Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Biochim. Biophys. Acta 2000; 1463: 209-218. (Pubitemid 30081781)
64. Volynsky PE, Polyansky AA, Simakov NA, Arseniev AS, Efremov RG. Effect of lipid composition on the 'membrane response' induced by a fusion peptide. Biochemistry 2005; 44: 14626-14637.
65. Pabst G, Grage S, Danner-Pongratz S, Jing W, Ulrich AS, Watts A, et al. Membrane thickening by the antimicrobial peptide PGLa. Biophys. J. 2008; 95: 5779-5788.